Expert Consensus
International Consensus on Severe Lung Cancer—The Second Edition
Xinqing Lin, Qian Chu, Yuchao Dong, Min Li, Tangfeng Lv, Gen Lin, Ling Sang, Panwen Tian, Yang Xia, Zhanhong Xie, Haiming Chen, Cheng Hong, Juan Jiang, Haoru Jin, Zhongkai Kuai, Ming Liu, Weizhan Luo, Yongbei Luo, Qian Miao, Wei Mo, Dan Pu, Yuan Qiu, Zhe Qian, Jiancong Sun, Hui Shi, Qinying Sun, Yutao Sun, Zihui Yu, Xiaohong Xie, Wanting Xu, Minxiao Yi, Dongmei Yuan, Longfeng Zhang, Fei Zhao, Changhao Zhong, Ping Zhan, Xiaobin Zheng, Cunxue Bai, Enguo Chen, Rui Chen, Xin Chen, Yuan Cheng, Quanfang Chen, Linbo Cai, Xiuyu Cai, Liangan Chen, Yan Chen, Wen Dong, Haiyi Deng, Wenfeng Fang, Xin Gan, Yue Hao, Weidong Hu, Yong He, Yi Hu, Jie Hu, Baohui Han, Chengping Hu, Minjuan Hu, Yongliang Jiang, Yang Jin, Dan Liu, Weiting Liu, Wen Li, Jing Li, Laiyu Liu, Jun Liu, Weifeng Li, Wenhua Liang, Jie Lin, Hongbing Liu, Ziming Li, Weimin Li, NiHong Lu, Shun Lu, Chuanyong Mu, Hongxia Ma, Liyun Miao, Xinlin Mu, Xingxiang Pu, Jing Peng, Hongbing Peng, Jianwen Qin, Yinyin Qin, Shengxiang Ren, Longhua Sun, Chunxia Su, Yong Song, Xiaowu Tan, Kejing Tang, Xiaomei Tang, Jianlin Tong, Wenxian Wang, Di Wu, Lin Wu, Mengzhao Wang, Huijuan Wang, Yuehong Wang, Hongmei Wang, Qi Wang, Zhijie Wang, Jie Wang, Kai Wang, Fei Wang, Chunwei Xu, Min Xie, Aiguo Xu, Kui Xiao, Xin Xu, Fei Xu, Xianwei Ye, Meng Yang, Boyan Yang, Xiaoqun Ye, Feng Ye, Zongyang Yu, Dongsheng Yue, Qichuan Zhang, Juntao Zou, Jian Zhang, Li Zhuang, Jianying Zhou, Jianya Zhou, Bicheng Zhang, Jian Zhang, Jianqing Zhang, Xiaoju Zhang, Wei Zhao, Bo Zhu, Zhengfei Zhu, Wenzhao Zhong, Caicun Zhou, Yanbin Zhou, Jianxing He, Nanshan Zhong, Yuichi Saito, Satoshi Watanabe, Francesco Petrella, Takeo Nakada, Taichiro Goto, Alfonso Fiorelli, Piergiorgio Solli, Rossana Berardi, Yoshinobu Ichiki, Marcin Braun, Misako Nagasaka, Christos Chouaïd, Rajat Thawani, Pedro Gonzalez Santa-Catalina, Kim Styrvoky, Baptiste Abbar, Mariano Provencio, Shiyue Li, Rongchang Chen, Chengzhi Zhou
Abstract
Following the 2021 first International Consensus on Severe Lung Cancer, global attention to patients with PS 2–4 has grown significantly. Recent advances in novel therapies, interventional techniques, and supportive care, along with emerging real world data, have expanded treatment opportunities for this population. To incorporate these advances, we have updated the consensus.